DaVita Inc. (NYSE:DVA) Shares Sold by Creative Financial Designs Inc. ADV

Creative Financial Designs Inc. ADV decreased its holdings in shares of DaVita Inc. (NYSE:DVAFree Report) by 23.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,063 shares of the company’s stock after selling 318 shares during the period. Creative Financial Designs Inc. ADV’s holdings in DaVita were worth $159,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in DVA. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita during the fourth quarter worth $41,000. Quarry LP acquired a new stake in shares of DaVita during the third quarter worth $60,000. Venturi Wealth Management LLC raised its position in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after buying an additional 152 shares during the period. Versant Capital Management Inc raised its position in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after buying an additional 169 shares during the period. Finally, Blue Trust Inc. raised its position in shares of DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after buying an additional 131 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on DVA shares. Sanford C. Bernstein set a $184.00 target price on DaVita in a research report on Friday, February 21st. Barclays increased their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $166.33.

Get Our Latest Stock Analysis on DaVita

DaVita Trading Up 0.4 %

NYSE:DVA opened at $150.00 on Thursday. The business’s 50-day moving average is $158.73 and its two-hundred day moving average is $157.55. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The firm has a market capitalization of $12.00 billion, a PE ratio of 13.97, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVAGet Free Report) last announced its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

About DaVita

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Articles

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.